Compumedics Ltd - Asset Resilience Ratio

Latest as of June 2022: 16.97%

Compumedics Ltd (CMP) has an Asset Resilience Ratio of 16.97% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Compumedics Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$7.08 Million
≈ $5.01 Million USD Cash + Short-term Investments

Total Assets

AU$41.71 Million
≈ $29.51 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2022)

This chart shows how Compumedics Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Compumedics Ltd (CMP) total assets.

Liquid Assets Composition Over Time

This chart breaks down Compumedics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Compumedics Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$7.08 Million 16.97%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$7.08 Million 16.97%

Asset Resilience Insights

  • Good Liquidity Position: Compumedics Ltd maintains a healthy 16.97% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Compumedics Ltd Industry Peers by Asset Resilience Ratio

Compare Compumedics Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
Medical Devices 18.80%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 3.90%
Hi-Clearance
TWO:1788
Medical Devices 2.55%
MODULIGHT OY EO 1
F:78W
Medical Devices 15.99%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%

Annual Asset Resilience Ratio for Compumedics Ltd (2016–2022)

The table below shows the annual Asset Resilience Ratio data for Compumedics Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-06-30 16.97% AU$7.08 Million
≈ $5.01 Million
AU$41.71 Million
≈ $29.51 Million
+5.08pp
2019-06-30 11.90% AU$4.60 Million
≈ $3.25 Million
AU$38.66 Million
≈ $27.36 Million
+0.62pp
2018-06-30 11.27% AU$3.91 Million
≈ $2.76 Million
AU$34.65 Million
≈ $24.52 Million
-2.76pp
2017-06-30 14.03% AU$4.10 Million
≈ $2.90 Million
AU$29.23 Million
≈ $20.68 Million
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$26.12 Million
≈ $18.48 Million
--
pp = percentage points

About Compumedics Ltd

AU:CMP Australia Medical Devices
Market Cap
$35.34 Million
AU$49.94 Million AUD
Market Cap Rank
#23315 Global
#878 in Australia
Share Price
AU$0.25
Change (1 day)
+6.38%
52-Week Range
AU$0.22 - AU$0.45
All Time High
AU$0.90
About

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more